Obalon Strengthens Balance Sheet By Raising Additional Capital And Reducing Debt
Throughout the second quarter of 2019, Obalon raised approximately
“We are pleased to have been able to utilize our multi-pronged approach to raise capital and improve our balance sheet,” said
To the extent that statements contained in this press release are not descriptions of historical facts regarding
President & Chief Financial Officer
Office: +1 760 607 5103
Source: Obalon Therapeutics, Inc.